Susquehanna International Group
KRRO icon

Susquehanna International Group’s Korro Bio KRRO Stock Holding History

Susquehanna International Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$986K Buy
+87,100
New +$959K ﹤0.01% 7921
2023
Q3 		– Sell
-254
Closed -$4.45K – 12512
2023
Q2 		$4.45K Sell
254
-350
-58% -$6.79K ﹤0.01% 11834
2023
Q1 		$15.1K Buy
+604
New +$68.8K ﹤0.01% 12117
2022
Q4 		– Sell
-586
Closed -$52K – 13093
2022
Q3 		$52K Sell
586
-760
-56% -$77.1K ﹤0.01% 12175
2022
Q2 		$101K Buy
1,346
+890
+195% +$60.2K ﹤0.01% 11467
2022
Q1 		$48K Sell
456
-528
-54% -$101K ﹤0.01% 12330
2021
Q4 		$252K Sell
984
-998
-50% -$303K ﹤0.01% 10916
2021
Q3 		$700K Sell
1,982
-2,992
-60% -$1.18M ﹤0.01% 8508
2021
Q2 		$2.48M Buy
4,974
+1,336
+37% +$652K ﹤0.01% 5440
2021
Q1 		$1.73M Buy
3,638
+2,702
+289% +$5.25M ﹤0.01% 6274
2020
Q4 		$1.65M Buy
+936
New +$1.24M ﹤0.01% 5520

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Susquehanna International Group's KRRO Position: Q1 2026 in Review

Susquehanna International Group sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 196,827 shares — an estimated $2.17M sold.

Susquehanna International Group first reported a position in KRRO in Q3 2020 and held it in 13 quarters. The position peaked at $1.58M in Q4 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Susquehanna International Group reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 196,827 Korro Bio shares in Q1 2026, an estimated $2.17M.
  • Susquehanna International Group first reported a position in Korro Bio in Q3 2020 and held it in 13 quarters.
  • Susquehanna International Group's Korro Bio position peaked at $1.58M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.